Here’s a brief look at medications for rheumatologic disorders that were approved or granted a new indication in 2018.
Higher Risk of Interstitial Lung Disease in Patients With RA, PsA Initiating bDMARDs
Emerging Agents in the Treatment of Rheumatic Diseases
Substituting Medical Cannabis for Medications Improved Rheumatic Disease Symptom Management
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
Anti-tTG, EMA Antibodies Implicated in Fibromyalgia in Patients With Celiac Disease
Abdominal Fat Linked to Chronic Musculoskeletal Pain, Particularly in Women